shutterstock_749771347_scotyard

Scotyard / Shutterstock.com

21 April 2020Big PharmaDaphne Lainson and Nancy Pei

Compulsory licensing in Canada—revisited

On March 25, 2020, the government of Canada acted swiftly to enact legislation in response to COVID-19. The legislation, which was introduced into Parliament just the day before, brought sweeping changes to various aspects of Canadian law, including expanding the compulsory licensing framework in the Patent Act.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

UK govt backs ventilator makers against potential IP complaints

16 April 2020 The UK government will indemnify ventilator manufacturers from the financial burden arising from any potential IP breaches, as health services around the world scramble to up their capacity of the devices.

Canada authorises compulsory licences for COVID-19 shortfalls

27 March 2020 Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.

More on this story

UK govt backs ventilator makers against potential IP complaints

16 April 2020 The UK government will indemnify ventilator manufacturers from the financial burden arising from any potential IP breaches, as health services around the world scramble to up their capacity of the devices.

Canada authorises compulsory licences for COVID-19 shortfalls

27 March 2020 Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.

More on this story

UK govt backs ventilator makers against potential IP complaints

16 April 2020 The UK government will indemnify ventilator manufacturers from the financial burden arising from any potential IP breaches, as health services around the world scramble to up their capacity of the devices.

Canada authorises compulsory licences for COVID-19 shortfalls

27 March 2020 Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.

More features

Sanofi successfully challenges rare disease patent in Europe

WATCH: Policy direction—where are we now?

BMS faces fresh lawsuit over alleged cancer drug monopoly

WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations

Boies Schiller Flexner adds three-strong litigation team

AstraZeneca forced to clarify deal terms in row with university

Novartis loses cancer drug patent following Teva challenge at EPO

Biotech seeks to stop Kirkland from representing rival in Eylea dispute